Key facts
- Osstec’s last known valuation is $14.9M (Mar 2025).
- It has raised $6.5M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Innovate UK, SFC Capital, SyndicateRoom, Parkwalk Advisors, Imperial Enterprise Lab — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Osstec
- ·The full record, as it builds
Funding rounds
No funding rounds for Osstec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Osstec
Developer of advanced orthopaedic implants designed for knee replacement surgeries. The company's implants mimic the porous structure of bone, allowing for natural load transfer, reducing stress shielding, and promoting bone ingrowth, enabling patients with osteoarthritis to achieve long-term implant stability and an improved quality of life.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2021
- Employees
- 11
- Website
- osstec.uk/
- Ownership
- Privately Held (backing)
Osstec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Osstec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Osstec in its N-PORT filings yet. We sweep new filings monthly.